Background Information on David Lilley
Most recently, David Lilley led the Commercial arm of NovaQuest from 2005 to 2008 where he and his team executed deals to provide services "at risk" surrounding the launch and subsequent support of products on a global basis. These efforts also involved the coordination of multiple sales and marketing services associated with Quintiles and Innovex, which was achieved through the Global Alliance Management function at Quintiles. This function also reported to Mr. Lilley.
From 1987 to 2005, Mr. Lilley served in various executive management roles including Global President at Innovex, which was acquired by Quintiles in 1996. Mr. Lilley was appointed to the Board of Directors of Innovex in 1989 and successfully moved the company into a clinical research arena initially providing clinical research associates and monitors to companies on a contract basis before becoming a full-service CRO in 1991.
Prior to his time at Innovex, Mr. Lilley worked for Johnson & Johnson in the United Kingdom for seven years, holding several marketing and sales positions at the company.
About Campbell Alliance
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function: Brand Management, Business Development, Clinical Development, Managed Markets, Medical Affairs, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan. For more information o
|SOURCE Campbell Alliance|
Copyright©2009 PR Newswire.
All rights reserved